Skip to main content

Table 4 Known-groups validity and the discriminatory power of EQ-5D-3 L and EQ-5D-5 L

From: Comparing the performance of the EQ-5D-3 L and the EQ-5D-5 L in an elderly Chinese population

  EQ-5D-3 L EQ-5D-5 LF5L/F3L
n (%)Mean (SD)F-statisticn (%)Mean (SD)F-statistic
Metabolic syndrome
 No66 (20.4)0.899 (0.144) *2.74267 (20.7)0.952 (0.101) *5.5042.007
 Yes258 (79.6)0.862 (0.169) 257 (79.3)0.916 (0.113)  
Osteoporosis
 No180 (55.6)0.900 (0.152) *14.635181 (55.9)0.955 (0.090) *35.9022.453
 Yes144 (44.4)0.831 (0.172) 143 (44.1)0.884 (0.124)  
Arthritis
 No255 (78.7)0.871 (0.174)0.194261 (80.5)0.932 (0.115)0.2361.216
 Yes69 (21.3)0.862 (0.126) 63 (19.5)0.929 (0.090)  
Other chronic condition
 No261 (80.6)0.870 (0.161)0.056261 (80.5)0.932 (0.108)0.0801.429
 Yes63 (19.4)0.864 (0.179) 63 (19.5)0.926 (0.125)  
Acute medical condition
 No290 (89.5)0.874 (0.163) *2.411306 (94.4)0.926 (0.108) *2.7971.160
 Yes34 (10.5)0.828 (0.176) 18 (5.6)0.881 (0.158)  
  1. Note EQ-5D EuroQol five-dimensional questionnaire, EQ-5D-3 L (3 L) three-level version of the EQ-5D, EQ-5D-5 L (5 L) five-level version of the EQ-5D, SD Standard deviation
  2. * p<0.05(t tests of the difference between known groups)